JORDAN LIDSKY-EVERSON: Open Payments
NPI 1508570367 · MERIDEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,827 in 71 payments from 27 companies in 2025. Trend: 2023 $417 · 2024 $473 · 2025 $1,827
Food & beverage: $1,554Education: $273
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 7 | $201 |
| E.R. Squibb & Sons, L.L.C. | 9 | $177 |
| Janssen Biotech, Inc. | 3 | $158 |
| Celgene Corporation | 10 | $136 |
| Astellas Pharma US Inc | 5 | $127 |
| SOBI, INC | 2 | $124 |
| Novartis Pharmaceuticals Corporation | 3 | $95 |
| JAZZ PHARMACEUTICALS INC. | 3 | $73 |
| Coherus Oncology, Inc. | 3 | $70 |
| EMD Serono, Inc. | 2 | $63 |
Products named: RYBREVANT, OPDIVO, Fabhalta, OPDUALAG, Vyloy, REBLOZYL, LOQTORZI, JAKAFI.
Industry payments across CT — which companies pay providers there.
